Porter Health
Understanding Inflammation & hsCRP
A Patient's Guide to Inflammation, Atherosclerosis, and Cardiovascular Risk
Inflammation is your body's natural defense system - it helps fight infections and heal injuries. But when inflammation becomes chronic (long-lasting and low-grade), it can damage your arteries and lead to heart disease.
The Inflammation-Heart Disease Connection:
Think of inflammation as a "fire" inside your arteries. This fire helps cholesterol particles (LDL) burrow into artery walls, where they form plaques. Over time, inflamed plaques can rupture, causing blood clots that lead to heart attacks and strokes.
Key Insight: You can have "normal" cholesterol levels but still be at high risk if you have high inflammation. This is why measuring inflammation (through hsCRP) is so important.
How Atherosclerosis Develops:
Important: Inflammation is now recognized as a major independent risk factor for heart disease - just as important as cholesterol, blood pressure, and diabetes.
hsCRP is a blood test that measures inflammation in your body. C-reactive protein (CRP) is made by your liver in response to inflammation anywhere in your body. The "high-sensitivity" version can detect even small amounts of chronic inflammation.
What hsCRP Tells You:
How the Test Works:
Sample: Simple blood test (usually fasting not required)
Results: Measured in milligrams per liter (mg/L)
Cost: Typically covered by insurance when medically indicated
Timing: Repeat test 2 weeks later if elevated to confirm (inflammation can vary day-to-day)
The American Heart Association and CDC classify cardiovascular risk based on hsCRP levels:
Low Risk
hsCRP: Less than 1 mg/L
Your inflammation levels are low, indicating lower cardiovascular risk from inflammation. This is the ideal range.
What to do:
Maintain healthy lifestyle habits to keep inflammation low. Recheck every 3-5 years or if risk factors change.
Moderate Risk
hsCRP: 1-3 mg/L
Your inflammation is moderately elevated, indicating intermediate cardiovascular risk. This is a warning sign to take action.
What to do:
Focus aggressively on lifestyle changes (diet, exercise, weight loss, stress reduction). Discuss preventive medications with your doctor if other risk factors are present.
Recheck hsCRP in 3-6 months to see if lifestyle changes are working.
High Risk
hsCRP: Greater than 3 mg/L
Your inflammation is significantly elevated, indicating high cardiovascular risk. This level doubles your risk of heart attack compared to hsCRP <1 mg/L.
What to do:
1. Rule out infection or acute illness: Repeat test in 2 weeks. hsCRP can spike temporarily with infections, injuries, or flare-ups of inflammatory conditions.
2. Aggressive lifestyle intervention: All the strategies listed below (diet, exercise, weight loss, stress management).
3. Consider statin therapy: Even if cholesterol is "normal," statins reduce inflammation and cardiovascular events (see JUPITER trial below).
Very High (Greater than 10 mg/L)
This level suggests acute inflammation - possibly an infection, injury, or inflammatory disease flare-up.
Action Required:
Contact your doctor to investigate the cause. Rule out infection, autoimmune disease, or other inflammatory conditions. Retest after treatment to assess baseline cardiovascular inflammation.
The JUPITER trial (2008) was a groundbreaking study that changed how we think about inflammation and heart disease prevention.
What the JUPITER Trial Showed:
Who Was Studied:
17,802 people with "normal" LDL cholesterol (<130 mg/dL) but elevated hsCRP (>2 mg/L). These were people who wouldn't normally be considered for statin therapy based on cholesterol alone.
What Was Done:
Half received rosuvastatin 20mg (Crestor), half received placebo. The trial was designed to run for 5 years.
Dramatic Results (Trial Stopped Early!):
The trial was stopped after only 1.9 years because the benefits were so clear it was unethical to continue giving placebo:
• 44% reduction in heart attacks
• 54% reduction in strokes
• 48% reduction in heart disease deaths
• 20% reduction in all-cause mortality
Mechanism:
Statins not only lowered LDL by 50%, but also reduced hsCRP by 37%. This dual action on cholesterol AND inflammation explains the dramatic benefits.
What JUPITER Means for You:
If you have elevated hsCRP (>2 mg/L) - even with normal cholesterol - you may benefit from statin therapy. Talk to your doctor about whether the JUPITER findings apply to you.
Number needed to treat: Only 25 people need treatment for 2 years to prevent one heart attack, stroke, or death.
Current Guidelines: The 2026 ACC/AHA dyslipidemia guidelines include hsCRP as a "risk-enhancing factor" that can tip the decision toward starting statin therapy in people at borderline or intermediate risk. Notably, hsCRP ≥2 mg/L on two successive occasions at borderline risk now supports high-intensity statin therapy (COR 2a).
Good News: Lifestyle changes can significantly lower hsCRP
Studies show that diet, exercise, weight loss, sleep, and stress management can reduce hsCRP by 30-50% or more - often bringing high-risk levels down to low-risk range.
1. Anti-Inflammatory Diet
Effect: Mediterranean diet can lower hsCRP by 20-40%
- Fatty fish (salmon, sardines, mackerel) - rich in omega-3s
- Colorful fruits and vegetables (berries, leafy greens, tomatoes)
- Nuts and seeds (walnuts, flaxseeds, chia seeds)
- Olive oil (extra virgin)
- Whole grains (oats, quinoa, brown rice)
- Beans and legumes
- Green tea
- Dark chocolate (70%+ cocoa)
- Processed foods and fast food
- Refined carbohydrates (white bread, pastries)
- Sugary drinks and sweets
- Red meat and processed meats
- Trans fats (partially hydrogenated oils)
- Excessive alcohol
- Fried foods
2. Regular Exercise
Effect: Can lower hsCRP by 30-40% within 6-12 weeks
Exercise Goals:
- Aerobic: 150+ minutes per week moderate activity (brisk walking, swimming, cycling)
- Vigorous: 75+ minutes per week (running, HIIT, intense sports)
- Strength training: 2 days per week (weights, resistance bands, bodyweight)
- Start gradually - even 10-15 minutes daily provides benefit
- Consistency is key - regular exercise has cumulative anti-inflammatory effects
3. Weight Loss (if overweight)
Effect: Every 1 kg (2.2 lbs) lost lowers hsCRP by ~0.13 mg/L. Losing 10% body weight can reduce hsCRP by 30%+
Why: Excess body fat (especially belly fat) produces inflammatory chemicals. Losing weight reduces this inflammatory burden.
Even modest weight loss (5-10% of body weight) significantly lowers inflammation.
4. Adequate Sleep
Effect: Poor sleep increases hsCRP. Getting 7-9 hours nightly can reduce inflammation by 20-30%
Sleep Quality Matters:
- Aim for 7-9 hours per night consistently
- Maintain regular sleep schedule (same bedtime/wake time)
- Screen sleep apnea if you snore or have daytime fatigue
- Create dark, cool, quiet sleep environment
5. Stress Management
Effect: Chronic stress raises hsCRP. Stress reduction techniques can lower it by 15-25%
Evidence-Based Stress Reduction:
- Meditation or mindfulness practice (10-20 min daily)
- Deep breathing exercises
- Yoga or tai chi
- Regular physical activity (dual benefit!)
- Social connection and support
- Professional counseling if needed
6. Quit Smoking
Smoking dramatically increases inflammation and hsCRP levels. Quitting reduces hsCRP within weeks to months.
Ask your doctor about smoking cessation programs, nicotine replacement therapy, or medications like varenicline (Chantix) or bupropion (Wellbutrin).
7. Treat Underlying Inflammatory Conditions
Chronic inflammatory diseases raise hsCRP and cardiovascular risk.
Common Conditions to Manage:
- Rheumatoid arthritis, lupus, psoriatic arthritis (work with rheumatologist)
- Inflammatory bowel disease (Crohn's, ulcerative colitis)
- Chronic infections (gum disease, H. pylori)
- Obstructive sleep apnea (CPAP therapy reduces inflammation)
hsCRP is not a routine test for everyone. It's most useful in specific situations to help assess cardiovascular risk when other tests are inconclusive.
Consider hsCRP Testing If:
When NOT to Test:
• During acute illness, infection, or injury (wait 2-4 weeks after recovery)
• If you already have established heart disease (you're already high risk, treatment decisions don't change)
• If you're already on statin therapy (result won't change management)
• If cardiovascular risk is clearly low or clearly high (won't change treatment plan)
Not Specific to Heart Disease
hsCRP measures total body inflammation, not just artery inflammation. Levels can be elevated by infections, injuries, autoimmune diseases, obesity, or chronic pain. This is why repeat testing is important to establish a baseline.
Can Fluctuate
hsCRP can vary by 20-30% day-to-day due to normal biological variation, stress, sleep, recent meals, etc. If elevated, always repeat the test 2 weeks later to confirm.
Not a Substitute for Other Tests
hsCRP is an additional tool, not a replacement for cholesterol testing, blood pressure monitoring, or glucose screening. It provides complementary information about cardiovascular risk.
No Target hsCRP Level (Yet)
Unlike LDL cholesterol or blood pressure, there's no agreed-upon treatment target for hsCRP. The goal is simply "lower is better." Lifestyle changes and statins both reduce hsCRP, but we treat based on overall cardiovascular risk, not hsCRP alone.
Use this checklist to guide your conversation about inflammation and cardiovascular risk:
Inflammation is a major independent risk factor for heart disease - as important as cholesterol
hsCRP measures chronic inflammation and predicts cardiovascular events
hsCRP thresholds: <1 mg/L (low risk), 1-3 mg/L (moderate), >3 mg/L (high risk)
JUPITER trial showed statins reduce heart attacks by 44% in people with elevated hsCRP (even with normal cholesterol)
Lifestyle changes (diet, exercise, weight loss, sleep, stress) can lower hsCRP by 30-50%
Mediterranean diet is powerfully anti-inflammatory
hsCRP testing is most useful for intermediate-risk patients to guide treatment decisions
Always repeat elevated hsCRP in 2 weeks to confirm (can fluctuate with infections)
Lower is better - but no specific treatment target yet (focus on overall cardiovascular risk)
References:
This guide is based on clinical evidence from the JUPITER trial and American Heart Association/American College of Cardiology guidelines on using inflammatory biomarkers for cardiovascular risk assessment.
Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. N Engl J Med. 2008;359(21):2195-2207. doi:10.1056/NEJMoa0807646
Ridker PM. Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention. Circulation. 2003;107(3):363-369. doi:10.1161/01.CIR.0000053730.47739.3C
Pearson TA, Mensah GA, Alexander RW, et al. Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice. Circulation. 2003;107(3):499-511. doi:10.1161/01.CIR.0000052939.59093.45